BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2004
View Archived Issues
Hypolipidemic effects of GW-707 occur via disruption of intracellular sterol trafficking
Read More
CETP and HDL: potential targets for the prevention of cardiovascular disease
Read More
Vardenafil improves erection and depression in patients with erectile dysfunction
Read More
Shire acquires U.K., Ireland marketing rights for Reminyl
Read More
Chiesi and Novartis enter Italian agreement for HFA Formoterol pMDI
Read More
Trials with Guidant's two everolimus-eluting stents begin and complete enrollment
Read More
NCI grant supports development of multiepitope cancer vaccine at Epimmune
Read More
SBIR grant funds development of discodermolide analogue production
Read More
Series C financing at Salmedix will fund pipeline progression
Read More
Screening acceptance letter for open-label extension study of Tectin
Read More
BioCurex Serum-RECAF test detects 90% of lung cancer in study
Read More
Ovation acquires North American rights for Sabril and Frisium from Aventis
Read More
Novel TNF-alpha inhibitors presented by Procter & Gamble
Read More
Lilly describes novel potent and selective 5-HT1F receptor agonists
Read More
BAY-43-9006 receives fast track status
Read More
Phase II trial of FM-VP4 meets primary endpoint
Read More
Development of NeuroVax supported by ITN grant
Read More
Pivotal phase III trial studies teduglutide for short bowel syndrome
Read More
Abbott completes acquisition of TheraSense
Read More
Remicade sBLA accepted for first-line use in early RA
Read More
BN-82002, a Cdc25 phosphatase inhibitor, supports possible target for cancer treatment
Read More
University of Pittsburgh discovers competitive Cdc25B inhibitor
Read More
Abbott's A-382535 demonstrates antiproliferative and apoptotic effects in human cancer cell lines
Read More
New antibacterial ketolides developed at Enanta
Read More
New modulators of nAchR and/or monoamine transporters claimed by NeuroSearch
Read More
Quinoline-based PARP inhibitors newly discovered at Kyorin
Read More
Novel beta2-adrenoceptor agonists and their use in respiratory disorders
Read More
New HIV protease inhibitors designed by Tibotec scientists
Read More
New prodrugs of beta-lactamase inhibitors covered by Pfizer patent
Read More
